Daschle, Peanut Butter Put FDA Commissioner Choice In Sticky Situation
This article was originally published in The Gray Sheet
Executive Summary
The withdrawal of Tom Daschle's nomination as HHS secretary may delay the announcement of an FDA commissioner, but does not change the two names on the Obama administration's shortlist
You may also be interested in...
GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products
The Government Accountability Office added enhanced oversight of devices, drugs and other medical products to its list of "high-risk" priorities in a report to Congress released Jan. 22
HHS Deputy Corr Could Reignite Debate Over FDA Tobacco Oversight
HHS Secretary-designate Tom Daschle's pick of William Corr as deputy secretary will be a key policy appointment should the Obama administration decide to make FDA regulation of tobacco a priority
Race For FDA Commissioner Almost Over: Will It End With Sharfstein Or Califf?
The Obama transition team has concluded its search for a new FDA commissioner, stakeholders said late last week